<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="85513">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01704950</url>
  </required_header>
  <id_info>
    <org_study_id>RECON-EMEA-11</org_study_id>
    <nct_id>NCT01704950</nct_id>
  </id_info>
  <brief_title>Clinical Outcome of Defect Reconstruction Using IDRT Single Layer : Results From a Prospective Multicentric Trial</brief_title>
  <official_title>Clinical Outcome of Defect Reconstruction Using IDRT Single Layer : Results From a Prospective Multicentric Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Integra LifeSciences Services</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Integra LifeSciences Services</source>
  <oversight_info>
    <authority>France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé</authority>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <authority>Greece: Ethics Committee</authority>
    <authority>United Kingdom: National Health Service</authority>
    <authority>Italy: Ethics Committee</authority>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to provide data and the guidelines for the use of IDRT SL in small
      wounds, acute and chronic (less than 6 months), showing the benefits and the easy to use of
      this product as a one stage procedure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Rate of graft take</measure>
    <time_frame>Day 15 after the surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>the mean percentage of healing expected at Day 15 after the surgery</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Traumatic Wound</condition>
  <condition>Reconstruction Wound</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Global population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  Patient with 1 traumatic wound (burns included) or 1 reconstruction wound
             (oncological wounds included)

          -  Patients for whom the surgeon has recommended that an INTEGRA® SL matrix be implanted
             (even if the patient is not taking part in the study) with a Split Thickness Skin
             Graft in the same operating procedure

          -  Wound treated with only one layer of a maximum size 10cm*12.5cm

        Exclusion Criteria:

          -  Immunosuppressed patient

          -  Chronic wound (with no healing since 6 months)

          -  Addition of any substances (growth factor, stem cells,…) in the IDRT SL during the
             surgery

          -  Patient with a corticoid treatment with a daily dose greater than 5 mg

          -  Patients whose life expectancy is less than 12 months

          -  Patients whose mental health or health condition (Visual deficiency, Alzheimers…)
             would compromise completion of the self-evaluation questionnaires

          -  Patient with an hypersensitivity to bovine collagen, chondroitin

          -  Patient with clinical signs of infection (fever, pain, colour, swelling,…) and for
             whom the investigator diagnosed infection
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefanos Papadopoulos</last_name>
    <role>Principal Investigator</role>
    <affiliation>General State Hospital of Athens, &quot;G. Gennimatas&quot;</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marilyne Blanc</last_name>
    <phone>33437475937</phone>
    <email>marilyne.blanc@integralife.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>St Josef Hospital</name>
      <address>
        <city>Bochum</city>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Falk G. Bechara</last_name>
    </contact>
    <investigator>
      <last_name>Falk G. Bechara</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dimitrios Georgas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Schapoor Hessam</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General State Hospital of Athens, &quot;G. Gennimatas&quot; - Department of Plastic Surgery-Microsurgery and Burn Center</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stefanos Papadopoulos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital &quot;S. Maria della Misericordia&quot; - Plastic Surgery and Burn Center</name>
      <address>
        <city>Udine</city>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mauro Schiavon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital - Burn and Plastic Surgery</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2WB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Steven Jeffery</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Greece</country>
    <country>Italy</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 11, 2013</lastchanged_date>
  <firstreceived_date>October 9, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
